STOCK TITAN

Ketamine Wellness Centers (KWC) Announces Grand Opening of Reno Clinic

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Ketamine Wellness Centers (KWC), a subsidiary of Delic Holdings Corp, has opened a new clinic in Reno, Nevada, increasing the total to 13 clinics across nine states. This 2,200 square-foot facility aims to provide affordable mental health treatments for conditions like anxiety and depression. KWC Reno, which follows the company's expansion strategy, is expected to serve both local patients and those from California lacking in-state providers. CEO Kevin Nicholson emphasizes the importance of affordable mental health care during the ongoing crisis.

Positive
  • KWC has expanded its clinic network to 13 locations across nine states.
  • Reno clinic aims to increase access to affordable mental health treatments for anxiety, depression, and PTSD.
  • The facility will attract patients from California, addressing a gap in affordable care.
Negative
  • None.

GILBERT, AZ, March 16, 2022 /PRNewswire/ - Ketamine Wellness Centers (KWC), the largest ketamine therapy provider in the U.S. and a subsidiary of Delic Holdings Corp ("Delic" or the "Company") (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), has expanded its presence within the state of Nevada with the opening of its Reno location.

KWC Reno is the second of the company's clinics to open in Nevada within the last 18 months, bringing the total number of KWC clinics to 13 across nine states. The 2,200 square-foot treatment facility will not only serve local patients, but it will also open its doors to patients in larger California markets who do not have access to affordable in-state providers. KWC Reno is the latest in a series of state-of-the-art clinics that Delic will open over the next 18 months. Through these openings, the Company will expand access to reasonably priced treatments for various mental health conditions.

"With the pandemic entering its third year, the need for effective and affordable mental health treatment is critical. KWC Reno expands our footprint to serve so many more individuals suffering from treatment-resistant anxiety, depression and PTSD to further combat the country's on-going mental health crisis," said Kevin Nicholson, CEO of KWC and Chief Operating Officer for Delic. "We look forward to providing the most effective and personalized treatments to patients in both Nevada and California."

LOCATION: KWC Reno (1895 Plumas Street, Suite 6)

DETAILS:
To commemorate the grand opening, KWC Reno will offer tours of the clinic to the media by appointment.

For more information about Ketamine Wellness Centers' locations, services and hours of operation, please visit https://www.ketaminewellnesscenters.com/locations/.

About Ketamine Wellness Centers
Ketamine Wellness Centers (KWC) is the largest ketamine therapy provider in the United States with 13 clinic locations serving communities across nine states. Since 2011 KWC has been a trusted leader in bringing IV ketamine therapy into mainstream health care. KWC has provided over 60,000 treatments to clinically eligible patients, from young adults to seniors, in addition to developing specialized programs for veterans and first responders. The KWC team, including a core group of physicians, psychologists, clinicians, and executives, is dedicated to providing value-based, personalized, clinically controlled ketamine infusion care for people suffering from treatment-resistant depression, anxiety, PTSD, OCD and chronic pain. KWC's scalable business and treatment model is designed for further rapid expansion along with breakthrough innovations in effective therapies and services.

About Delic Corp
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation on psychedelics. The company owns and operates an umbrella of related businesses, including the largest chain of psychedelic wellness clinics in the country, Ketamine Wellness Centers; the only licensed entity by Health Canada to exclusively focus on research and development of psilocybin vaporization technology, Delic Labs; the premier psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and effective treatment options to the masses.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and does not accept responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell, or a solicitation of an offer to buy, any securities ‎in the United States. The securities have not been and will not be registered ‎under the United States ‎Securities Act of 1933, as amended (the "U.S. Securities Act"), or any state ‎securities laws and may not be offered or ‎sold within the United Statesunless registered under the U.S. ‎Securities Act and applicable state securities laws or an ‎exemption from such registration is available.‎

Forward-Looking Information and Statements
This press release contains certain "forward-looking information" within the meaning of applicable ‎Canadian securities ‎legislation and may also contain statements that may constitute "forward-looking ‎statements" within the meaning of ‎the safe harbor provisions of the United States Private Securities ‎Litigation Reform Act of 1995. Such forward-looking ‎information and forward-looking statements are not ‎representative of historical facts or information or current ‎condition, but instead represent only the ‎Company's beliefs regarding future events, plans or objectives, many of ‎which, by their nature, are ‎inherently uncertain and outside of Delic's control. Generally, such forward-looking ‎information or ‎forward-looking statements can be identified by the use of forward-looking terminology such as ‎‎"plans", ‎‎"expects" or "does not expect", "is expected", "budget", "scheduled", "estimates", "forecasts", "intends", ‎‎‎"anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or may ‎contain ‎statements that certain actions, events or results "may", "could", "would", "might" or "will be ‎taken", "will continue", ‎‎"will occur" or "will be achieved". The forward-looking information and forward-‎looking statements contained herein ‎may include, but are not limited to: information regarding the timing or terms upon which the Transaction will be completed; potential benefits of the Transaction;  anticipated continued growth in the health and wellness sector (and, in particular, related to psychedelics); the ability of Delic to successfully achieve business ‎objectives, ‎and expectations ‎for other economic, ‎business, and/or competitive factors.‎

By identifying such information and statements in this manner, Delic is alerting the reader that ‎such ‎information and statements are subject to known and unknown risks, uncertainties and other factors ‎that may cause ‎the actual results, level of activity, performance or achievements of Delic to be ‎materially different from those ‎expressed or implied by such information and statements. Such risks and other factors may include, but are not limited to: risks and uncertainties relating to the Transaction not closing as planned or at all or on terms and conditions set forth in the Merger Agreement; incorrect assessment of the value and potential benefits of the Transaction; direct and indirect material adverse effects from the COVID-19 pandemic; inability to obtain future financing on suitable terms; failure to obtain required regulatory and other approvals; risks inherent in the psychedelic treatment sector; changes in applicable laws and regulations; and failure to comply with applicable laws and regulations.

In addition, in connection with the forward-looking ‎information and forward-looking statements contained in this press ‎release, Delic has made certain ‎assumptions. These assumptions include, but are not limited to: assumptions as to the time required to negotiate a definite agreement and complete matters related to the Transaction; the ability to consummate the Transaction; ‎the ability of the parties to ‎obtain, in a timely manner, the requisite regulatory, corporate and other third party approvals and the satisfaction of ‎other conditions to the ‎consummation of the Transaction on the proposed terms; the potential impact of the announcement or consummation of the Transaction on ‎relationships, ‎including with regulatory bodies, employees, suppliers, customers and competitors; ‎changes in general economic, ‎business and political conditions, including changes in the financial ‎markets; changes in applicable laws; compliance ‎with extensive government regulation; and the diversion ‎of management time on the Transaction.‎

Should one or more of these risks, uncertainties or other factors materialize, or should assumptions ‎underlying the ‎forward-looking information or statements prove incorrect, actual results may vary ‎materially from those described ‎herein as intended, planned, anticipated, believed, estimated or ‎expected.‎

Although Delic believes that the assumptions and factors used in preparing, and the expectations ‎contained ‎in, the forward-looking information and statements are reasonable, undue reliance should not ‎be placed on such ‎information and statements, and no assurance or guarantee can be given that such ‎forward-looking information and ‎statements will prove to be accurate, as actual results and future events ‎could differ materially from those anticipated ‎in such information and statements. The forward-looking ‎information and forward-looking statements contained in this ‎press release are made as of the date of ‎this press release, and Delic does not undertake to update any ‎forward-looking information ‎and/or forward-looking statements that are contained or referenced herein, except in ‎accordance with ‎applicable securities laws. All subsequent written and oral forward- looking information and ‎statements ‎attributable to Delic or persons acting on its behalf is expressly qualified in its entirety by this ‎‎notice.‎

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ketamine-wellness-centers-kwc-announces-grand-opening-of-reno-clinic-301503533.html

SOURCE Delic Holdings Inc.

FAQ

What is the significance of the new KWC Reno clinic opening on March 16, 2022?

The KWC Reno clinic opening expands access to affordable mental health treatments in Nevada and California, addressing the rising demand due to ongoing mental health issues.

How many clinics does Ketamine Wellness Centers now operate after the Reno opening?

After the Reno opening, Ketamine Wellness Centers operates a total of 13 clinics across nine states.

What types of treatments will the new KWC Reno clinic offer?

KWC Reno will offer affordable ketamine therapy for treatment-resistant anxiety, depression, PTSD, and other mental health conditions.

Who is the CEO of Ketamine Wellness Centers and what did he say about the new Reno clinic?

Kevin Nicholson is the CEO of KWC, and he highlighted the critical need for effective mental health treatment in the U.S. as the pandemic continues.

What is the address of the new KWC Reno clinic?

The KWC Reno clinic is located at 1895 Plumas Street, Suite 6, Reno, Nevada.

DELIC HOLDINGS CORP

OTC:DELCF

DELCF Rankings

DELCF Latest News

DELCF Stock Data

88
71.78M
13.85%
Internet Content & Information
Communication Services
Link
United States of America
Vancouver